These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28698321)

  • 41. Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza.
    Khazeni N; Bravata DM; Holty JE; Uyeki TM; Stave CD; Gould MK
    Ann Intern Med; 2009 Oct; 151(7):464-73. PubMed ID: 19652173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
    N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
    Hayden FG; Sugaya N; Hirotsu N; Lee N; de Jong MD; Hurt AC; Ishida T; Sekino H; Yamada K; Portsmouth S; Kawaguchi K; Shishido T; Arai M; Tsuchiya K; Uehara T; Watanabe A;
    N Engl J Med; 2018 Sep; 379(10):913-923. PubMed ID: 30184455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials.
    Lalezari J; Campion K; Keene O; Silagy C
    Arch Intern Med; 2001 Jan; 161(2):212-7. PubMed ID: 11176734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
    Kohno S; Yen MY; Cheong HJ; Hirotsu N; Ishida T; Kadota J; Mizuguchi M; Kida H; Shimada J;
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5267-76. PubMed ID: 21825298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.
    Hayden FG; Treanor JJ; Fritz RS; Lobo M; Betts RF; Miller M; Kinnersley N; Mills RG; Ward P; Straus SE
    JAMA; 1999 Oct; 282(13):1240-6. PubMed ID: 10517426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial.
    Heinonen S; Silvennoinen H; Lehtinen P; Vainionpää R; Vahlberg T; Ziegler T; Ikonen N; Puhakka T; Heikkinen T
    Clin Infect Dis; 2010 Oct; 51(8):887-94. PubMed ID: 20815736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
    N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A population pharmacokinetic analysis of zanamivir in subjects with experimental and naturally occurring influenza: effects of formulation and route of administration.
    Peng AW; Hussey EK; Moore KH
    J Clin Pharmacol; 2000 Mar; 40(3):242-9. PubMed ID: 10709152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A meta-analysis of laninamivir octanoate for treatment and prophylaxis of influenza.
    Higashiguchi M; Matsumoto T; Fujii T
    Antivir Ther; 2018; 23(2):157-165. PubMed ID: 28869418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The truth about Tamiflu? Zanamivir should be inhaled, not nebulised.
    Eagel BA
    BMJ; 2010 Jan; 340():c131. PubMed ID: 20071426
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiviral therapy and prophylaxis for influenza in children.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
    Jefferson T; Jones M; Doshi P; Del Mar C
    BMJ; 2009 Dec; 339():b5106. PubMed ID: 19995812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.
    Nicholson KG; Aoki FY; Osterhaus AD; Trottier S; Carewicz O; Mercier CH; Rode A; Kinnersley N; Ward P
    Lancet; 2000 May; 355(9218):1845-50. PubMed ID: 10866439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coadministration of orally inhaled zanamivir with inactivated trivalent influenza vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of healthy volunteers.
    Webster A; Boyce M; Edmundson S; Miller I
    Clin Pharmacokinet; 1999; 36 Suppl 1():51-8. PubMed ID: 10429840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized double-blind controlled study of laninamivir compared with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases.
    Watanabe A
    J Infect Chemother; 2013 Feb; 19(1):89-97. PubMed ID: 22907567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
    J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
    Carrat F; Duval X; Tubach F; Mosnier A; Van der Werf S; Tibi A; Blanchon T; Leport C; Flahault A; Mentré F;
    Antivir Ther; 2012; 17(6):1085-90. PubMed ID: 22910171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An uncontrolled open-label, multicenter study to monitor the antiviral activity and safety of inhaled zanamivir (as Rotadisk via Diskhaler device) among Chinese adolescents and adults with influenza-like illness.
    Cao B; Wang DY; Yu XM; Wei LQ; Pu ZH; Gao Y; Wang J; Dong JP; Li XL; Xu Q; Hu K; Chen BY; Yu YS; Song SF; Shu YL; Wang C
    Chin Med J (Engl); 2012 Sep; 125(17):3002-7. PubMed ID: 22932170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.